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Abstract A rapid and continuous proteolysis of tryptophan hy- 
droxylase was demonstrated with two mast cell lines derived from 
rat basophilic leukemia cells (RBL2H3) and mouse mastocytoma 
(FMA3). Under conditions in which protein biosynthesis was ar- 
rested by administration of cycloheximide, the decay profile of 
tryptophan hydroxylase protein was traced by Western blot anal- 
ysis. Incorporation of [35S]methionine and the chase experiment 
performed without interfering with the metabolic stage also 
showed that tryptophan hydroxylase had been cleaved rapidly. 
The half life of the enzyme was 11-15 min in RBL2H3 cells and 
41)--60 min in FMA3 cells, and the process was demonstrated to 
be dependent on intracellular ATP. 
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1. Introduction 
The largest reservoirs of serotonin in the mammalian body 
are the blood circulation and the gastrointestinal mucosa [1,2]. 
Gastrointestinal enterochromaffin-cells and mast cells of ro- 
dents are serotonin producing whereas platelets are not. Most 
body serotonin in these animals is produced by these non- 
neural cells. Tryptophan hydroxylase is the rate limiting en- 
zyme of serotonin biosynthesis. The non-neural form of the 
enzyme has been described in gastrointestinal mucosa [3,4] and 
has also been studied in cultured cells of mouse mastocytoma 
origin [5 10]. The non-neural enzyme is a different entity from 
the neural enzyme. However, the molecular basis of the differ- 
ence between the two types has not been understood even after 
considerable investigation [7,8,11-13]. An immunohistochemi- 
cal study revealed that distribution of serotonin and tryptophan 
hydroxylase in murine gastrointestinal mucosa did not always 
parallel quantity [14]. Such heterogeneity of distribution sug- 
gests that the serotonin producing pathway is attenuated in 
relation to cell age, tissue specific localization, or to adaptation 
to physiological conditions. Little is known concerning the reg- 
ulation of peripheral serotonin production. Actually, RBL2H3 
cells show an increase in tryptophan hydroxylase activity as 
high as 10-fold within a short period after stimulations (to be 
published elsewhere). The aim here was to find a possible mech- 
anism which could afford a rapid restoration of storage sero- 
tonin after a vigorous discharge voked by immune stimulation. 
A rapid and continuous proteolysis of tryptophan hydroxylase 
was demonstrated in this study. This degradation was shown 
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to mask rapid biosynthesis under an apparent low steady state 
of enzyme activity in living but presumably resting cells. 
2. Materials and Methods 
Cycloheximide was purchased from Sigma (St.Louis, MO). The 
[35S]methionine and [35S]cysteine mixture (Tran35S-label) was purchased 
from ICN (Costa Mesa, CA). Dulbecco's Modified Eagle's Medium 
(DMEM), RPMI1640, and its methionine-free d rivatives were pur- 
chased from Gibco BRL (Gaithersburg, MD). Rabbit antiserum was 
raised against purified tryptophan hydroxylase of mouse mastocytoma, 
P815 [15]. RBL2H3, a mast cell line derived from basophilic leukemia 
cells, was obtained from The Japanese Cancer Research Resources 
Bank (Tokyo). RBL2H3 cells were kept as a monolayer culture in 
DMEM containing 10% fetal calf serum and under 5% COJ95% air. 
FMA3 cells of a mouse mastocytoma cell line were maintained as a 
suspension culture in RPMI 1640 containing 10% fetal calf serum. Five 
hours before analyses, cells were placed in serum-free media buffered 
with hepes/NaOH instead of with NaHCO3/CO2 alone. 
Hydroxylation of tryptophan i  living cells under monolayer culture 
was estimated by measuring accumulation of 5-hydroxy-L-tryptophan 
(5HTP) after administration f a high dose of NSD-1015, an inhibitor 
of aromatic L-amino acid decarboxylase. Cells were placed in fresh 
culture medium containing 400/IM NDS-1015 and kept at 37°C for 
30 min. The culture was terminated by addition of 5% ascorbic acid in 
1 M HCI. The whole culture including the medium was subjected to 
analysis of accumulated 5HTP. 
Cell-free nzyme activity was determined essentially as described [15] 
with the modifications mentioned below. Culture medium was removed 
by suction (in the case of a monolayer culture of RBL2H3) or by 
centrifugation (FMA3). Cells were placed in 20 ¢tl of phosphate buff- 
ered saline then subjected twice to freezing in liquid nitrogen and thaw- 
ing in running tap water. The disrupted cells were incubated in the 
mixture consisted of 30 mM DTT, 50/IM Fe 2+, 4 mg/ml catalase in 0.1 
M Tris-acetate (pH 8.1) for 10 rain at 30°C. Then, another cocktail was 
added to complete the reaction mixture, resulting in a final concentra- 
tion of tryptophan; 250 pM, 6R-tetrahydrobiopterin; 400pM, NADH; 
500pM and NSD-1015 1 mM, catalase; 2 mg/ml and 4.5 ¢tg/ml of sheep 
liver dihydropteridine r ductase (Sigma). The reaction was allowed to 
proceed for 10 min at 300C. The 5HTP formed was measured using 
high performance liquid chromatography. 
Methionine incorporation was performed as follows. The cells were 
incubated at 37°C for 60 min in methionine-free medium buffered with 
hepes/NaOH containing 10% dialyzed fetal calf serum. The cells were 
then exposed to [35S]methionine (7.4 MBq/ml, 41.88 TBq/mmol) dis- 
solved in methionine-free medium. For the chase xperiments, he radi- 
oactive medium was replaced with non-radioactive medium enriched 
with 5 x methionine and the culture continued. Since radioactive cyste- 
ine was diluted with the non-radioactive amino acid in the methionine- 
free medium, we neglected to consider the possible contribution of the 
labelling of cysteine residues. The culture was terminated and solubil- 
ized by addition of 1% NP-40 in 50 mM Tris-HC1 (pH 7.8), then 
immunoprecipitation was performed using rabbit polyclonal anti-tryp- 
tophan hydroxylase serum as the primary antibody and Staphylococcal 
ghosts (Pansolbin, Calbiochem, La Jolla, CA) as a precipitant. The 
precipitates were subjected to SDS-polyacrylamide el ctropboresis fol- 
lowed by fluorographic analysis. 
Western blot analysis: after SDS-polyacrylamide gelelectrophoresis, 
proteins were transferred to a nitrocellulose filter (Advantec, Tokyo) 
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by electrophoresis across the gel [16]. The proteins were visualized using 
rabbit polyclonal anti-tryptophan hydroxylase serum as the primary 
antibody and horse radish peroxidase-conjugated goat antibody to 
rabbit IgG (Wako, Tokyo) as the secondary antibody. 
3. Results 
3.1. Disappearance of tryptophan hydroxylase after 
cycloheximide treatment 
The accumulation rate of 5HTP after administration of a 
sufficient amount of NSD-1015 was about 0.44).7 pmol/min/ 
106 cells under culture. The intracellular activity of tryptophan 
hydroxylase was very sensitive to cycloheximide. Administra- 
tion of this reagent at concentrations a low as 0.1/zg/ml virtu- 
ally abolished intracellular hydroxylation of tryptophan to 
5HTP within 4 h (Fig. 1). We examined whether the slowdown 
of the intracellular process was due to the disappearance of
tryptophan hydroxylase or to other factors. Enzyme activity 
was therefore measured in a cell-free assay system. The cell-free 
enzyme activity of RBL2H3 cells was 4.68 + 1.76 pmol/min/106 
cells (n = 24). A rapid disappearance of tryptophan hydrox- 
ylase activity was observed after administration of cyclo- 
heximide (10/zg/ml) to these cells (Fig. 2a). Cycloheximide 
concentrations higher than 10/,tg/ml did not appear to make 
the decrease more rapid in the tryptophan hydroxylase activity. 
Western blot analysis of cell extracts prepared after cells were 
treated for a short-period with cycloheximide demonstrated a 
corresponding decrease in the amount of tryptophan hydrox- 
ylase protein of which the reported molecular weight is 53,000 
Daltons [17] (Fig. 2b), The enzyme activity after 30 min of 
exposure to cycloheximide (10 #g/ml) was less than 50% of the 
initial level (the half life was roughly 11 rain based on data of 
the first 60 min). After washing cycloheximide out of the culture 
medium, about 50% of the initial enzyme level was restored 
within 1 h, indicating that cellular functionality remained intact 
(data not shown). With FMA3 cells, the observed 50%-decay 
time was 40-60 min and the initial level of tryptophan hydrox- 
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Fig. 1. Inhibition of protein biosynthesis abolishes endogenous conver- 
sion of tryptophan to5HTP in RBL2H3 cells. RBL2H3 cells (average 
density: 1.5 x 105 cells per well of a 96-well microassay plate) were 
placed in serum-free DMEM buffered with hepes-NaOH 1 h prior to 
the experiment, then treated with the indicated concentrations ofcyclo- 
heximide for 4 h. The culture medium of each well was then replaced 
with fresh media nd 400 ~M NSD-1015 were added for 5HTP accumu- 
lation, as described in section 2 (n = 6 for each point). 
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Fig. 2. Effect of arresting protein biosynthesis by cycloheximide. 
RBL2H3 cells were exposed to cycloheximide (1#g/ml) for the indi- 
cated periods. (a) Tryptophan hydroxylase activity was measured with 
disrupted cells, as described in section 2. (b) After the indicated times 
of cycloheximide administration, cells were sonicated. Extracts were 
then prepared by centrifugation at12,000 rpm for 10 min and subjected 
to SDS-polyacrylamide g l electrophoresis for Western blot analysis. 
TPH: tryptophan hydroxylase. 
ylase activity was 100-150 pmol/min/106 cells, roughly 30-fold 
higher than with RBL2H3 cells. 
3.2. Pulse chase of tryptophan hydroxylase labeled with 
FS S ]methionine 
The question remained as to whether the observed rapid 
degradation was due to an artifact evoked by administration 
of cycloheximide. In order to clarify this point, turnover was 
examined without administering cycloheximide. Tryptophan 
hydroxylase was labeled in situ by incorporation of 
[35S]methionine, then immunoreactive protein bands were 
chased using specific antiserum. On labeling, only a faint band 
was recognized corresponding to the intact subunit of trypto- 
phan hydroxylase (Mr = 53,000), whereas an extremely dense 
band with an Mr<20,000 appeared early and continued to 
increase in density (Fig. 3a). In the chase experiment (Fig. 3b), 
the presumably intact subunit faded with time, corresponding 
to the observed ecay time of enzyme activity. In the similar 
experiments using FMA3 cells, an even more faint band with 
an Mr = 53,000 appeared (data not shown). These results indi- 
cate that newly synthesized tryptophan hydroxylase was nearly 
simultaneously degraded. 
3.3. Dependence onATP 
In order to observe the dependence of this process on ATE 
metabolic inhibitors were applied to the cell to deplete ATP 
within the cell. RBL2H3 cells were placed in 2,4-dinitrophenol 
(0.5 raM) and 2-deoxyglucose (30 raM) in the absence of cyclo- 
heximide, however, tryptophan hydroxylase activity stayed at 
the initial level for about 1 2 min then dropped as if protein 
biosynthesis were blocked, leaving the degradation process un- 
changed. Simultaneous administration of these reagents with 
cycloheximide did not yield significantly different results from 
those using cycloheximide alone. With FMA3 cells of the 
mouse mastocytoma cell line, the effect of cycloheximide was 
effectively antagonized by the addition of the two reagents as 
shown in Fig. 4. Either 2,4-dinitrophenol (0.5 mM) alone or 
2-deoxyglucose (30 mM) did not completely remove the effect 
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of cycloheximide. These reagents did not raise the level of 
tryptophan hydroxylase in the absence of cycloheximide. 
4. Discussion 
We previously demonstrated that a large proportion of tryp- 
tophan hydroxylase is in quiescent form in specific regions 
[3,4,10]. The major limiting factor preventing the enzyme from 
being fully active is most probably an insufficient supply of 
intracellular ferrous iron [18]. The actual activity of tryptophan 
hydroxylase in RBL2H3 cells was only one tenth of the poten- 
tial activity of the enzyme under our culture conditions used. 
Furthermore, the intracellular hydroxylation of tryptophan 
was very sensitive to cycloheximide, suggesting that the enzyme 
system might depend on the 'fragile' component. The possibil- 
ity that the 'fragile' component was tryptophan hydroxylase 
itself was supported by the following: (1) enzyme activity meas- 
ured in the cell-free system also decreased after cycloheximide 
administration, (2) concomitant protein degradation was visu- 
alized by Western blot analysis using specific antiserum, and 
(3) rapid turnover was observed without using cycloheximide 
by means of a radioisotope tracer technique. The rapid disap- 
pearance of tryptophan hydroxylase by cycloheximide treat- 
ment was demonstrated to be closely dependent on ATP pro- 
duction in the cell (Fig. 4), suggesting that the proteolysis was 
an ATP- dependent process in the cell. Since the biosynthesis 
of tryptophan hydroxylase and its degradation seem to be 
counter-balanced under ordinary conditions, we expected that 
temporary depletion of ATP would lead to a transient rise in 
the amount of enzyme, if the decrease in the biosynthesis would 
commence after any delay. However, we could not observe this 
rise in both lines of cells. In the case of RBL2H3 cells, in which 
tryptophan hydroxylase disappears faster than in FMA3 cells, 
the enzyme did not maintain its level in the presence of 2,4- 
dinitrophenol (0.5 mM) and 2-deoxyglucose (30 raM) even in 
the absence of cycloheximide (data not shown). This indicates 
that the protein biosynthesis of tryptophan hydroxylase in 
RBL2H3 cells was even more sensitive to ATP depletion. The 
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Fig. 3. Incorporation of [35S]methionine to tryptophan hydroxylase 
and disappearance of the major peptide. RBL2H3 cells were fed with 
[35S]methionine for 5 min (left). The cells were then washed and kept 
in non-radioactive culture medium (right). Proteins collected by im- 
munoprecipitation by using polyclonal anti-tryptophan hydroxylase 
rabbit serum were subjected to SDS-polyacrylamide g l electrophore- 
sis. A protein band correspondent to tryptophan hydroxylase (indi- 
cated as TPH, Mr = 53,000) was very faint. A protein band correspon- 
dent to tryptophan hydroxylase (indicated as TPH, Mr = 53,000) was 
very faint. A very dense band, close to the dye front, appeared and 
increased in the early incubation (right), then decreased in the chase 
(left). Thin lines represent marker proteins, from top to bottom; 94k, 
67k, 43k, 30k, and 21.1k (14.4k was not separated from 21.1k). 
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Fig. 4. Dependence oftryptophan hydroxylase turnover on intracellu- 
lar ATP. At zero-time, FMA3 cells (3 x 105 cells/ml) were placed in 10 
pg/ml of cycloheximide alone (©), or in the presence of 2,4-dinitrophe- 
nol (A, 500 BM) or 2-deoxyglucose (v,30 mM), or both 2A-dinitrophe- 
nol and 2-deoxyglucose (e). 
measured half life of tryptophan hydroxylase in the typical 
cases depicted in Figs. 2 and 3 was about 10 to 15 min. How- 
ever, the half life of tryptophan hydroxylase in this cell line 
varied widely between 10 to more than 60 min in RBL3H3 cells. 
It was also noted that steady state enzyme activity varied 
widely, as mentioned above. We speculated that the steady state 
level may be primarily determined by degradation ata constant 
rate of biosynthesis. If this were the case, working out the 
equation for equilibrium dynamics would give a solution indi- 
cating that the steady state level is proportional to the half life. 
However, we could find no positive correlation between the half 
life and the steady state level of tryptophan hydroxylase (corre- 
lation coefficient, r =-0 .47 with 18 experiments), indicating 
that the rate of biosynthesis was not constant in each cells of 
the different culture. Since the biosynthetic rate must be equal 
to the degradation rate over the short term, cells with a high 
rate of enzyme production would have an even higher rate of 
enzyme degradation. We are not able to offer a reasonable 
explanation for these observations as yet. Nevertheless, rapid 
proteolysis i  obviously a major influence in determining the 
content of tryptophan hydroxylase in the cell. The rate of deg- 
radation may be sensitive to the cell's physiological conditions. 
The half life of tryptophan hydroxylase in the rat central 
nervous system and in the spinal cord was reported to be 2-3 
days [19] and the decay rate in rat raphe dorsalis was found to 
be 0.3-0.4 days -~ [20]. These rates are too slow to be compatible 
with a rapid regulatory response. Dumas et al. reported that the 
mRNA level of tryptophan hydroxylase was much higher in 
pineal gland than in the brain stem. They concluded that trans- 
lation was regulated ifferently in these tissues but they did not 
report on protein turnover. Sitaram and others examined the 
well-known instability of pineal tryptophan hydroxylase and 
found that the enzyme's half life was 75 min as measured in rats 
following administration fcycloheximide [21]. Rapid inactiva- 
tion of the enzyme may have resulted in degradation via non- 
specific cellular scavenging mechanisms. Our results suggest 
that rapid turnover is driven by specific proteolysis targeting 
tryptophan hydroxylase rather than by a mopping-up mecha- 
nism for scavenging unwanted proteins. The mechanism by 
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which the proteolytic process is boosted by ATP remains to be 
elucidated. 
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